pharmaphorum

JULY 4, 2025

European pharma trade group EFPIA has said that a strategy launched by the EU to bolster the region's standing in life sciences is a "step forward.

72

72

Express Pharma

JULY 4, 2025

Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent are bioequivalent to Atrovent Nasal Spray, 0.03 per cent and 0.06 per cent, of Boehringer Ingelheim Pharmaceuticals. Ipratropium Bromide Nasal Solution (Nasal Spray) 0.03 per cent is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennia

78

78

The Pharmacist

JULY 4, 2025

A revamped NHS App will help patients manage and remember their prescriptions and guide them on their specific drug reaction and interaction risks, according to the government’s 10 year plan for the NHS. The ‘Fit for the future: 10 year health plan for England,’ released yesterday, will include a ‘My Medicines’ tool on the App […] The post Updated NHS App to help patients manage prescriptions appeared first on The Pharmacist.

66

66

Pharmafile

JULY 4, 2025

The US Food and Drug Administration (FDA) has granted accelerated approval to Dizal Therapeutic’s Zegfrovy (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 20 insertion mutations. This covers patients whose disease has progressed following platinum-based chemotherapy.

Chemotherapy 93

Chemotherapy 93

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

European Pharmaceutical Review

JULY 4, 2025

Multiple blockbuster drugs set to lose exclusivity, producing one of the pharmaceutical industry’s most financially significant patent cliffs in over a decade, according to GlobalData. Oncology is one of the key therapy areas set to be affected by pricing pressures as drug patents expire. Pharma companies will need to “rethink revenue strategies, pipeline investments, and lifecycle management to safeguard long-term growth”, as a greater number of biosimilars and generic medicines gain market ent

Generic Medicine 52

Generic Medicine Biosimilars 52

Pharmafile

JULY 4, 2025

Johnson & Johnson has submitted an application to the European Medicines Agency for an indication extension of Akeega (niraparib and abiraterone acetate dual action tablet), aiming to treat adult patients with metastatic hormone-sensitive prostate cancer who carry homologous recombination repair (HRR) gene alterations. The submission builds on positive results from the company’s phase 3 AMPLITUDE […] The post Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatm

66

66

Pharmafile

JULY 4, 2025

In the second of the Gateway to Local Access series, Vision4Health caught up with Dr Graham Duce, ICB GP Prescribing and Clinical Lead, to discuss his views on the role of medicines operations teams in the new ICB structures. The post The quiet crisis: why medicines operations matter more than ever in the ICB era appeared first on Pharmafile.

59

59

Pharmaceutical Business Review

JULY 4, 2025

Tyzavan is indicated for the treatment of several serious infections in adults and children one month and above, including septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections. This new vancomycin is the only FDA-approved product that can be used directly from room temperature storage, eliminating the need for compounding, thawing, activation, or dilution.

Hospitals 52

Hospitals Compounding 52

Viseven

JULY 4, 2025

Research and development costs keep climbing, competition is fiercer than ever, and market entry barriers are at an all-time low. So, what do you do? Right – you make smarter marketing decisions. Advances in technology give us deeper insights into pharma industry trends and, more importantly, the reasons behind them. Understanding the “why” helps anticipate customer behaviors and identify opportunities that ensure the largest returns.

Communication 52

Communication Specialty Pharmacies 52

pharmaphorum

JULY 4, 2025

The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Express Pharma

JULY 4, 2025

The endometriosis market across the seven major markets (7MM*) is forecast to increase at a compound annual growth rate (CAGR) of 10.3 per cent from $938.0 million in 2024 to $2.5 billion in 2034, forecasts GlobalData. GlobalData’s latest report, “Endometriosis: Seven Market Drug Forecast and Market Analysis,” reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction of several key pipeline therapies, including Kissei Pharmaceutical’s Yselty (linzago

Labelling 93

Labelling Compounding 93

pharmaphorum

JULY 4, 2025

AstraZeneca passes another milestone in its journey to rebuild Imfinzi's presence in bladder cancer, a key growth driver for the drug

52

52

The Pharmacist

JULY 4, 2025

The Pharmacist speaks to recent Medallist of the Order of the British Empire (BEM) awardee and chair of Kent local pharmaceutical committee (LPC) Amish Patel on the changes he has seen at his Kent pharmacy and how his and role has evolved. When community pharmacist Amish Patel BEM went abroad to celebrate his 40th birthday, he […] The post Interview: BEM awardee Amish Patel reflects on royal recognition appeared first on The Pharmacist.

45

45

PharmaTech

JULY 4, 2025

Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.

40

40

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

JULY 4, 2025

The Pharmacist speaks to recent Order of the British Empire (OBE) awardee and chair of Kent local pharmaceutical committee (LPC) Amish Patel on the changes he has seen at his Kent pharmacy and how his and role has evolved. When community pharmacist Amish Patel OBE went abroad to celebrate his 40th birthday, he never imagined […] The post Interview: OBE awardee Amish Patel reflects on royal recognition appeared first on The Pharmacist.

40

40

Pharmacy Times

JULY 4, 2025

Recent research reveals that RSV and shingles vaccines significantly lower dementia risk, highlighting the potential benefits of AS01 adjuvants in vaccination.

Vaccines 42

Vaccines 42

Pharmafile

JULY 4, 2025

Biocon Biologics has announced that the European Commission has granted marketing authorisation for its denosumab biosimilars, Vevzuo and Evfraxy, marking a significant step in expanding patient access to critical bone health treatments across Europe. Vevzuo is approved for the prevention of skeletal complications in adults with advanced cancers involving bone, as well as for treating […] The post Biocon Biologics gains EU approval for bone health therapies appeared first on Pharmafile.

Biosimilars 52

Biosimilars 52

pharmaphorum

JULY 4, 2025

Closed & Collaborative H1 2025: Mergers, acquisitions, collaborations, and partnerships in life sciences Nicole.

65

65

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmacy Times

JULY 4, 2025

Six months following discharge from the hospital, adults who battled community-acquired pneumonia were at heightened risk of losing the ability to perform activities and experiencing poor quality of life.

Hospitals 40

Hospitals 40

pharmaphorum

JULY 4, 2025

Here, Michelle Tsai – chief operating officer at iOnctura – and Shane Olwill – chief development officer at Asgard Therapeutics – share their views on the broader cancer care landscape and ponder what’s hyped, what’s not being duly appreciated, and what might be coming next.

52

52

Pharmafile

JULY 4, 2025

Ingenza, a Scottish contract research, development and manufacturing organisation (CRDMO), has announced the appointment of Nick Challoner as chief executive officer, effective October 2025. With over three decades of leadership in chemical and biotech industries, Challoner’s arrival marks a key milestone in Ingenza’s growth strategy. Challoner most recently served as group chief scientific officer at […] The post Nick Challoner appointed CEO of Ingenza to drive further growth appeared fir

52

52

pharmaphorum

JULY 4, 2025

Onsite in Chicago at ASCO 2025, web editor Nicole Raleigh sat down with Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, one of the leading lung cancer experts there and who featured on several abstracts presented at the Congress this year.

52

52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

JULY 4, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Hospitals 52

Hospitals Packaging Communication Immunization 52

PharmaTech

JULY 4, 2025

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

Dosage 64

Dosage Drug Development Vaccines Diabetes 64

Pharmaceutical Technology

JULY 4, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Biosimilars 52

Biosimilars Chemotherapy Packaging Communication 52

Pharmacy Times

JULY 4, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Biosimilars 34

Biosimilars Specialty Pharmacies Pharmacy Technician Hospitals 34

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

JULY 4, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

EMCrit Project

JULY 4, 2025

Home EMCrit PulmCrit IBCC 1:1 ODR About About EMCrit PulmCrit – The Full Story EMCrit FAQ Subscribe to the Newsletter Contact Join Why Should I Become a Member? Questions Before Joining (FAQ) Join Now! EMCrit RACC Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation EMCrit Archives EDICUs Show Types ▿ 1:1 Nursing Podcast Foundational Stabilization (FoundStab) Project RACC-Lit CV-EMCrit Mind of the Resuscitationist Procedures Outside Shows You are here: H

Labelling 93

Labelling 93

Pharmaceutical Technology

JULY 4, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Drug Pricing 52

Drug Pricing Packaging Vaccines 52

Pharma and Life Sciences Blog

JULY 4, 2025

Building Automotive Supply Chains for What’s Next Pranil Fri, 07/04/2025 - 15:45 Geopolitical conflict. Rare-earth restrictions. EV demand spikes. For the automotive industry, supply chain disruption isn’t cyclical; it’s structural. Leaders are rethinking everything: where they source, how they plan and how fast they can pivot. It’s no longer about efficiency alone.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management